Related references
Note: Only part of the references are listed.Angiogenesis and anti-leukaemia activity of novel indole derivatives as potent colchicine binding site inhibitors
Yongfang Yao et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2022)
Design, synthesis, biological assessment, and in-Silico studies of 1,2,4-triazolo[1,5-a]pyrimidine derivatives as tubulin polymerization inhibitors
Heba S. Mohamed et al.
BIOORGANIC CHEMISTRY (2022)
Synthesis and Biological Evaluation of Highly Active 7-Anilino Triazolopyrimidines as Potent Antimicrotubule Agents
Paola Oliva et al.
PHARMACEUTICS (2022)
Novel 1,3,4-oxadiazole chalcogen analogues: Synthesis and cytotoxic activity
Stefano Zoroddu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
Design, semi-synthesis and bioactivity evaluation of novel podophyllotoxin derivatives as potent anti-tumor agents
Wenxue Sun et al.
BIOORGANIC CHEMISTRY (2022)
Discovery of highly potent tubulin polymerization inhibitors: Design, synthesis, and structure-activity relationships of novel 2,7-diaryl-[1,2,4]triazolo[1,5-a]pyrimidines
Xian-Sen Huo et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Discovery of new indole-based 1,2,4-triazole derivatives as potent tubulin polymerization inhibitors with anticancer activity
Fang Yang et al.
NEW JOURNAL OF CHEMISTRY (2021)
Design, synthesis, in vitro and in vivo biological evaluation of 2-amino-3-aroylbenzo[b]furan derivatives as highly potent tubulin polymerization inhibitors
Paola Oliva et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Exploration of carbamide derived pyrimidine-thioindole conjugates as potential VEGFR-2 inhibitors with anti-angiogenesis effect
Sravani Sana et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Synthesis, and biological evaluation of 3,6-diaryl-[1,2,4]triazolo[4,3-a] pyridine analogues as new potent tubulin polymerization inhibitors
Fang Yang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Pyrrolo[2′,3′:3,4]cyclohepta[1,2-d][1,2]oxazoles, a New Class of Antimitotic Agents Active against Multiple Malignant Cell Types
Virginia Spano et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Development of triazolothiadiazine derivatives as highly potent tubulin polymerization inhibitors: Structure-activity relationship, in vitro and in vivo study
Weifeng Ma et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Novel [1,2,4]triazolo [1,5-a]pyrimidine derivatives as potent antitubulin agents: Design, multicomponent synthesis and antiproliferative activities
Fang Yang et al.
BIOORGANIC CHEMISTRY (2019)
Triazolopyrimidine and triazolopyridine scaffolds as TDP2 inhibitors
Carlos J. A. Ribeiro et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
A Potent, Metabolically Stable Tubulin Inhibitor Targets the Colchicine Binding Site and Overcomes Taxane Resistance
Kinsie E. Arnst et al.
CANCER RESEARCH (2018)
Pyridine Based Antitumour Compounds Acting at the Colchicine Site
R. Alvarez et al.
CURRENT MEDICINAL CHEMISTRY (2016)
Triazolopyrimidines as a New Herbicidal Lead for Combating Weed Resistance Associated with Acetohydroxyacid Synthase Mutation
Yu-Chao Liu et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2016)
Design, Synthesis, and Biological Evaluation of 1-Methyl-1,4-dihydroindeno[1,2-c]pyrazole Analogues as Potential Anticancer Agents Targeting Tubulin Colchicine Binding Site
Yan-Na Liu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Design, synthesis and biological evaluation of novel 1,2,4-triazolo [3,4-b][1,3,4] thiadiazines bearing furan and thiophene nucleus
Bei Zhang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions
Naveen S. Vasudev et al.
ANGIOGENESIS (2014)
Synthesis, Antimitotic and Antivascular Activity of 1-(3′,4′,5′-Trimethoxybenzoyl)-3-arylamino-5-amino-1,2,4-triazoles
Romeo Romagnoli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Developing novel C-4 analogues of pyrrole-based antitubulin agents: weak but critical hydrogen bonding in the colchicine site
Chenxiao Da et al.
MEDCHEMCOMM (2013)
Synthesis and Biological Evaluation of 2,4,5-Substituted Pyrimidines as a New Class of Tubulin Polymerization Inhibitors
Fuchun Xie et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Syntheses and herbicidal activity of new triazolopyrimidine-2-sulfonamides as acetohydroxyacid synthase inhibitor
Chao-Nan Chen et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Class III β-tubulin expression and in vitro resistance to microtubule targeting agents
C. Stengel et al.
BRITISH JOURNAL OF CANCER (2010)
Microtubules and resistance to tubulin-binding agents
Maria Kavallaris
NATURE REVIEWS CANCER (2010)
Design and synthesis of N-2,6-difluorophenyl-5-methoxyl-1,2,4-triazolo[1,5-a]-pyrimidine-2-sulfonamide as acetohydroxyacid synthase inhibitor
Chao-Nan Chen et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Computational design and discovery of conformationally flexible inhibitors of acetohydroxyacid synthase to overcome drug resistance associated with the W586L mutation
Feng-Qin Ji et al.
CHEMMEDCHEM (2008)
Synthesis, antifungal activity and CoMFA analysis of novel l,2,4-triazolo[1,5-a]pyrimidine derivatives
Qiong Chen et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2008)
Is class III β-tubulin a predictive factor in patients receiving tubulin-binding agents?
Pascal Seve et al.
LANCET ONCOLOGY (2008)
Medicinal chemistry of combretastatin A4: Present and future directions
GC Tron et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Microtubules as a target for anticancer drugs
MA Jordan et al.
NATURE REVIEWS CANCER (2004)
Share Paper
